Caring Brands, Inc.
CABRHealthcare|Drug Manufacturers - Specialty & Generic|US
$1.02
+0.27 (+36.00%)
DCF Value
$0.15
Tangible Book / Share
$0.25
Cash / Share
$0.30
Financials
Financial Snapshot
Market Cap
$9.3M
Enterprise Value
$7.5M
Revenue (TTM)
$1.2K
Net Income (TTM)
-$7.7M
Cash & Investments
$1.8M
Net Cash
$1.8M
Free Cash Flow (TTM)
-$2.3M
Operating CF (TTM)
-$2.3M
Debt/Equity
0.00
Cash Runway & Burn Rate
Cash on Hand
$1.8M
Quarterly Burn
$563.8K
Monthly Burn
$187.9K
Est. Runway
~3.2 quarters
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Cash & Investments | $2.2M | $1.8M | |
| Operating Cash Flow | -$1.7M | -$2.3M | |
| Free Cash Flow | -$1.7M | -$2.3M | |
| Capital Expenditure | $0.00 | $0.00 | |
| Financing Cash Flow | $3.4M | $4.0M |
Income Statement
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Revenue | $4.2K | $1.2K | |
| Cost of Revenue | $1.9K | $473.00 | |
| Gross Profit | $2.3K | $687.00 | |
| R&D | $0.00 | $0.00 | |
| SG&A | $3.1M | $4.5M | |
| Operating Income | -$5.9M | -$7.1M | |
| Interest Expense | $19.2K | $306.2K | |
| Pretax Income | -$6.3M | -$7.7M | |
| Net Income | -$6.3M | -$7.7M | |
| EPS (Diluted) | -0.46 | -0.73 | |
| EBITDA | -$5.3M | -$4.2M | |
| Shares Out. (M) | 13.57 | 8.99 |
Balance Sheet
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Cash & Equivalents | $2.2M | $1.8M | |
| Short-Term Investments | $0.00 | $0.00 | |
| Total Current Assets | $2.3M | $1.9M | |
| Total Assets | $2.3M | $1.9M | |
| Total Current Liabilities | $176.8K | $384.6K | |
| Long-Term Debt | $58.6K | $0.00 | |
| Total Liabilities | $235.5K | $384.6K | |
| Stockholders' Equity | $2.1M | $1.5M | |
| Retained Earnings | -$7.1M | -$9.8M |
Cash Flow Statement
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | -$2.3M | |
| Capital Expenditure | $0.00 | $0.00 | |
| Free Cash Flow | -$1.7M | -$2.3M | |
| Investing Cash Flow | $0.00 | $0.00 | |
| Financing Cash Flow | $3.4M | $4.0M | |
| Issuance of Stock | $3.2M | $0.00 | |
| Repurchase of Stock | $0.00 | -$3.2M | |
| Net Debt Issuance | $170.0K | $4.1M | |
| Stock Based Comp. | $1.2M | $1.8M | |
| Net Change in Cash | $1.7M | $1.7M |
Dilution Tracker
Shares Outstanding
9M
5-Year Share Growth
+0.0%
Stock Issuance (TTM)
$0.00
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Shares Out. (M) | 13.57 | 8.99 | |
| Change vs Prior % | — | -33.7% | |
| Stock Issuance | $3.2M | $0.00 | |
| Stock Repurchase | $0.00 | -$3.2M | |
| Stock Based Comp. | $1.2M | $1.8M |
Margins & Profitability
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| Gross Margin % | 55.6% | 59.2% | |
| Operating Margin % | -140807.2% | -611753.0% | |
| Net Margin % | -148948.8% | -666037.8% | |
| EBITDA Margin % | -126003.0% | -360889.7% | |
| FCF Margin % | -40148.5% | -194398.3% | |
| ROE % | -300.2% | -386.2% | |
| ROA % | -269.8% | -404.6% | |
| ROIC % | -276.1% | -465.3% | |
| R&D / Revenue % | 0.0% | 0.0% |
Valuation
P/E (TTM)At Loss
P/S7994.26
P/B4.11
EV/EBITDAAt Loss
EV/Revenue6424.98
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.15
Tangible Book / Share
$0.25
Net Current Assets / Share
$0.17
Graham Net-Net
$0.23
Cash / Share
$0.30
| Metric | Trend | 2025 | TTM |
|---|---|---|---|
| P/E Ratio | -1.86 | -1.40 | |
| P/S Ratio | 2760.65 | 7994.26 | |
| P/B Ratio | 5.56 | 4.11 | |
| EV/EBITDA | -1.79 | -1.78 | |
| EV/Revenue | 2255.17 | 6424.98 |